(Q37778132)

23 August 2017

1 reference

title

Pauci-immune necrotizing glomerulonephritis (English)

1 reference

23 August 2017

Pauci-Immune Necrotizing Glomerulonephritis (English)

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

17 June 2024

1 reference

1 reference

4

Cees G M Kallenberg

1 reference

23 August 2017

Abraham Rutgers

1

1 reference

23 August 2017

Jan S. F. Sanders

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688250

17 June 2024

Coen A. Stegeman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688250

17 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20688250

17 June 2024

publication date

1 August 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0889857X10000414?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

https://api.elsevier.com/content/article/PII:S0889857X10000414?httpAccept=text/plain

17 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Rheumatic Diseases Clinics of North America

17 June 2024

published in

1 reference

23 August 2017

volume

36

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

559-572

1 reference

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts

17 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Renal involvement in Churg-Strauss syndrome

17 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Antineutrophil cytoplasmic autoantibodies and associated diseases: a review

17 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis

17 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis

17 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups

17 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement

17 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases

17 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies

17 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Determinants of vessel targeting in vasculitis

17 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Autoantibodies against glomerular endothelial cells in anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis

17 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Update on the glomerular filtration barrier

17 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Monocyte chemoattractant protein-1 and interleukin-8 levels in children with acute poststreptococcal glomerulonephritis

17 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis

17 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation

17 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.

17 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

EULAR recommendations for the management of primary small and medium vessel vasculitis.

17 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis

17 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

17 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review

17 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis

17 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment

17 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis

17 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

The clinical course of ANCA small-vessel vasculitis on chronic dialysis

17 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis

17 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Diagnostic predictive value of ANCA serology

17 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization

17 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

ANCA-negative pauci-immune crescentic glomerulonephritis

17 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome

17 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis

17 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease.

17 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre

17 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study

17 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis

17 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study

17 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidity

17 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement

17 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis

17 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Renal transplantation in systemic vasculitis: when is it safe?

17 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis

17 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.

17 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity

17 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan

17 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

17 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy

17 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Long-term treatment of relapsing Wegener's granulomatosis with 15-deoxyspergualin

17 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis

17 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

17 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.RDC.2010.05.002

17 June 2024

Identifiers

1 reference

23 August 2017

1 reference